BATTLEFORWORLD.COM | April 28, 2021: On Tuesday (April 27) the province of Quebec in Canada reported the first death of a patient from a rare blood clot condition after receiving the Western developed AstraZeneca COVID-19 jab.

So far Canada has recorded at least five cases of blood clot incidents after inoculation with the AstraZeneca vaccine, however the public health officials maintain that the benefits of the vaccine shot outweigh the potential risks.

(BattleForWorld.com: Medicine has degraded very badly, as people are told to take the jab and pray and hope they don't fall ill. What a disgrace.)

According to the Quebec Public Health Director Horacio Arruda to reporters, the death of the patient was due to thrombosis and that it will not change the province's vaccination strategy. (BattleForWorld.com: Oh my.) - That the rare complication, some regulators are calling Vaccine-Induced Prothrombotic Immune Thrombocytopenia, which causes blood clots accompanied by a low count of platelets, the cells in the blood that help it to clot.

The data amassed so far about the first cases of the extremely rare condition identified in those who received the AstraZeneca jab in Europe, where 40% died. Canadian health officials believe that the risk associated with the condition is likely to fall with increased awareness and early treatment.

"It's a calculated risk, but evidently when we think of this woman, her family, her close ones ... it's hard," Quebec Premier François Legault said of the 54-year-old woman patient.

...

AstraZeneca COVID-19 vaccine jab in vials.

END